- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04966910
Stay Connected: Testing an Intervention to Combat Coronavirus-related Social Isolation Among Older Adults
April 18, 2024 updated by: Michael Pullmann, University of Washington
Stay Connected: Testing an Intervention to Combat COVID-19 Related Social Isolation Among Seattle-area Older Adults
This study will use the University of Washington's ALACRITY Center's (UWAC) Discover, Design, Build, & Test (DDBT) method to develop and test an intervention to address the mental health health needs of older adults in senior housing ("clients") who are forced to not only shelter-in-place but cannot have family or other visitors during this time.
Older people (those over 60 years in age) are especially vulnerable and are more likely to have severe - even deadly - coronavirus infection than other age groups.
These facts led to the need to have older adults socially isolate in order to protect their health; visits with family and friends are limited, and in senior housing (independent, supported and assisted care residences) have limited such visits by family to one person a day.
This necessary practice of social distancing, while addressing an important public health crisis, unintentionally creates social isolation and loneliness, another deadly epidemic amongst the older population.
Even before COVID-19, social isolation and loneliness was a prominent mental health and social problem in the aged, one that is associated with increases in other chronic conditions, dementia and suicide.
Effective interventions for social isolation exist but are difficult to access and may not address all the concerns older adults have about this particular period of social isolation.
The purpose of this proposed study is to deploy an adaptation of Behavioral Activation Therapy called Stay Connected to treat depression in older adults.
The adaptation will allow activity directors and staff ("clinicians") in these settings and senior centers to deliver the therapeutic elements of the intervention (behavioral activation) in the context of social distancing/shelter-in-place policies.
Social workers in these settings will oversee the activity director and staff delivery of the intervention.
The investigators are working with a variety of senior housing types (HUD certified and private systems) and senior centers in Skagit county (rural) and King county (urban) in Washington (WA) so that the resulting intervention is not tied to economic levels or access to digital technology.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Clinicians and clients from 6 rural and urban senior communities or senior centers will participate in this study.
Senior communities or senior centers will be randomized to receive training and materials in either Stay Connected or a resource guide.
The investigators will work with 2 staff from each community or senior center and conduct baseline, 4 week and 9 week assessments with clinicians and 20 clients from each community setting (N=12 clinicians and 120 clients).
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Older Adult Participants
Inclusion Criteria:
- 60 years of age or older
- Physical and cognitive ability to complete interviews by phone or using video-chat technology (e.g., Zoom)
- English speaking
- Resident of participating Seattle-area senior living communities or member of Seattle-area senior centers
- Ability to provide consent
- Score of 5 or higher on Patient Health Questionnaire (PHQ-9) or score of 5 or higher on Generalized Anxiety Disorder Scale (GAD-7) or score of 6 or higher on University of California Los Angeles (UCLA) Loneliness Scale
- No suicidal ideation
Exclusion Criteria:
- Under the age of 60
- Inability to physically and/or cognitively consent and/or participate in study procedures via phone, computer, and/or video call
- Non-English speaking
- Scores below inclusion cut-offs on PHQ-9, GAD-7, and UCLA Loneliness Scale
Staff Participants Inclusion Criteria
- English-speaking
- Staff members in administration, social work, and/or activities department in Seattle area senior living communities or senior centers
- Physical ability to complete training in intervention and complete questionnaires by phone, computer, or video-chat technology
Exclusion Criteria
- Non-English speaking
- Unable to physically or cognitively consent and/or participate in study procedures via phone, computer, and/or video call (e.g., Zoom)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Stay Connected
Menu-driven set of strategies to combat loneliness, anxiety and depression in older adults
|
Stay Connected is a menu-driven set of strategies to combat loneliness, anxiety and depression in older adults based on behavioral activation principles.
|
|
Active Comparator: Treatment as usual
Treatment as usual in these practice settings typically includes regular check-in calls and offering resources and referrals
|
Regular check-ins, resource/referral provision
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
The PHQ-9 consists of 9 depression items and one disability item.
Each item is associated with a symptom of depression, which the participant rates whether or not they have experienced the symptom over the last two weeks, with severity rating of 0-3.
It is one of the few measures that is brief (it takes less than one minute to give) and has been found to have excellent sensitivity to change over time.
Older adult participants will complete this measure.
Total score ranges from 0 - 27 and higher scores indicate higher levels of depression symptoms.
|
Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
|
Generalized Anxiety Disorder (GAD-7)
Time Frame: Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
To assess for co-occurring anxiety, we will use the GAD-7, a 7- item screener for generalized anxiety.
It consists of items related to GAD.
Participants rate on a scale of 0-3 how much they have experienced in the last two weeks.
The scale is a valid screener for GAD.
Older adult participants will complete this measure.
Total score ranges from 0 - 21, with higher scores mean an increased degree of severity of anxiety symptoms.
|
Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
|
Sheehan Disability Scale (SDS)
Time Frame: Baseline, 4-Week Follow-Up and 9-Week Follow-Up
|
The SDS will be used as measure of disability/functional status.
This is a brief analog disability scale, which uses visual-spatial, numeric and verbal anchors.
The scale has been validated in medical and psychiatric populations with a variety of psychiatric diagnoses.
Older adult participants will complete this measure.
Total score ranges from 0 - 30, with higher scores indicating greater disruptions to their life from mental health symptoms.
|
Baseline, 4-Week Follow-Up and 9-Week Follow-Up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
University of California Los Angeles (UCLA) Loneliness Scale
Time Frame: Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
A 3-item scale designed to measure one's subjective feelings of loneliness as well as feelings of social isolation.
Participants rate each item as either O ("I often feel this way"), S ("I sometimes feel this way"), R ("I rarely feel this way"), N ("I never feel this way").
Older adult participants will complete this measure.
Total scores range from 3 - 9, with higher scores indicating higher levels of loneliness.
|
Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
|
Behavioral Activation Scale (BADS)
Time Frame: Client participants contributing Baseline, 4-Week Follow-Up, and 9-Week Follow-Up data, excluding cases missing at any timepoint.
|
The Behavioral Activation for Depression Scale (BADS) can be used to track changes weekly in the behaviors hypothesized to underlie depression and specifically targeted for change by behavioral activation.
It examines changes in the following areas: activation, avoidance/rumination, work/school impairment, and social impairment.
The BADS consists of 25 questions, each rated on a seven-point scale ranging from 0 (not at all) to 6 (completely).
Older adult participants will complete this measure.
Total scores range from 0 - 150, with higher scores indicating more behavioral activation.
|
Client participants contributing Baseline, 4-Week Follow-Up, and 9-Week Follow-Up data, excluding cases missing at any timepoint.
|
|
Patient Reported Outcome Measurement Information System (PROMIS) Social Isolation - Short Version
Time Frame: Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
The PROMIS Social Isolation item bank assesses perceptions of being avoided, excluded, detached, disconnected from, or unknown by, others.
This measure consists of 4 items, each rated on a five-point scale ranging from 1 - 5. Older adult participants will complete this measure.
Total scores range from 4 - 20, with higher scores meaning more social isolation.
|
Baseline, 4-Week Follow-Up, and 9-Week Follow-Up
|
|
Acceptability of Intervention Measure (AIM)
Time Frame: Baseline and 9 week follow up
|
This is a four item measure of intervention acceptability, where each item is rated on a 1-5 scale, with 1 = not at all acceptable and 5 = very acceptable, and the total score is a mean item score with minimum score of 1 and maximum of 5. Clinician participants complete this measure.
Higher values are considered to be more positive (i.e., a more acceptable intervention).
|
Baseline and 9 week follow up
|
|
Intervention Usability Scale (IUS)
Time Frame: 9 weeks
|
This is a ten item measure of how easy the intervention/system is to use and learn.
Used for interventions (e.g., therapeutic modalities).
Total scale scores range from 0 to 100, with higher scores considered to be more positive (i.e., a more usable intervention).
Scores of 70 and higher are considered to be a usable intervention.
Clinician participants complete this measure.
|
9 weeks
|
|
Intervention Appropriateness Measure (IAM)
Time Frame: Baseline, 9 week follow up
|
This is a four item measure of how suitable an intervention is for the circumstances, where each item is rated on a 1-5 scale, with 1 = not at all appropriate and 5 = very appropriate, and the total score is a mean item score with minimum score of 1 and maximum of 5. Clinician participants complete this measure.
Higher values are considered to be more positive (i.e., a more appropriate intervention).
|
Baseline, 9 week follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Patricia Arean, PhD, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 9, 2021
Primary Completion (Actual)
June 13, 2022
Study Completion (Actual)
June 13, 2022
Study Registration Dates
First Submitted
June 25, 2021
First Submitted That Met QC Criteria
July 15, 2021
First Posted (Actual)
July 19, 2021
Study Record Updates
Last Update Posted (Actual)
April 23, 2024
Last Update Submitted That Met QC Criteria
April 18, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00011051
- 5P50MH115837-03 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
Bekelu Teka WorkuJimma UniversityNot yet recruitingPrenatal Depression | Mental Health Related Quality of Life | Maternal Postpartum Depression | Paternal Postpartum DepressionEthiopia
Clinical Trials on Stay Connected
-
Uppsala UniversityRegion Stockholm; Uppsala County Council, Sweden; National Social Insurance Board... and other collaboratorsCompleted
-
Penang Hospital, MalaysiaCompletedContinuous Ambulatory Peritoneal DialysisMalaysia
-
VA Office of Research and DevelopmentCompleted
-
Hospices Civils de LyonUnknownTrend in Hospital Lengths of Stay and ReadmissionsFrance
-
University of KansasUniversity of North CarolinaRecruiting
-
ElsanActive, not recruiting
-
Spinal SingularityCompleted
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Memon Medical InstituteKhyber Teaching HospitalCompleted
-
DongGuk UniversityRecruitingIrritable Bowel Syndrome | Microbial ColonizationKorea, Republic of